Myfortic for the Treatment of Non-infectious Intermediate Uveitis
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The objective of this clinical trial is to evaluate the efficacy, safety and tolerability of
enteric-coated mycophenolate sodium (Myfortic®) in combination with low-dose corticosteroids
(Decortin H®) compared to a monotherapy with low-dose corticosteroids (Decortin H®) in
subjects with chronic intraocular inflammation (non-infectious intermediate uveitis).
Phase:
Phase 3
Details
Lead Sponsor:
STZ eyetrial
Collaborators:
Novartis Pharmaceuticals University Hospital Tuebingen